Current Portfolio
AMADIX
Cancer molecular diagnostics for early screening and diagnosis. Colofast: best in class blood...
Aglaris Cell
Developing a cell expansion platform for automated mesenquimal and T-cell culture...
ATLAS
First-in-class, innovative therapeutics for the treatment of Rare and Ultra-Rare Diseases.
Additum Blockchain
Exploring blockchain technology to improve efficiency, safety and patient value based healthcare.
Biocross
Blood based biomarkers for early diagnosis of Alzheimer Disease. First product APOE4 test.
NUUBO
The company designs, manufactures and sells a proprietary portfolio of innovative...
Mecwins
Developing a proprietary technology with subfemtogram ultrasensibility for protein...
OWL Metabolomics
Metabolomic platform with first marketed non invasive diagnostic LDT for NASH.
Oncovision
dedicated PET & Molecular Imaging for Breast Cancer, Neurodegeneration and Surgery.
Venter Pharma
Market stage diagnostic drug for hypolactasia.
Green Molecular
Pterostilbene formulations for derma and oncology
Historical Portfolio
Health In Code
Market stage company focused on molecular genetic diagnosis of familial cardiac diseases.
Iden Technologies
Proprietary technology platform for the evelopment of biostimulants and biopesticides.
TCD Pharma
First in class small molecule for the targeted treatment of solid tumors.
nLife Therapeutics
Discovery and development of oligonucleotides as therapeutic agents.
Raman Health Technologies
New non invasive diagnostic technology platform based on Raman laser and Infrarred...